Health
Penn Study Finds Solid-Tumor Cancer Patients Ineligible for Clinical Trials Receive Immunotherapy at Greater Rates Despite Lack of Benefits – pennmedicine.org
Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients…
PHILADELPHIA — Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients who are trial eligible despite no survival benefit, according to a new study by researchers at the Perelman School…
Continue Reading
-
Noosa News19 hours agoDangerous storm pounds south-east Queensland with giant hail, blackouts and widespread damage
-
Noosa News22 hours agoBruce Highway fatal: Grandmother’s heartbreak as daughter and granddaughter killed in Queensland truck crash
-
Noosa News22 hours agoPassenger footage of Sea World helicopters colliding
-
General10 hours agoXi Jinping tells Donald Trump Taiwan’s ‘return to China’ is key to international post-war order